Bausch Health Reports Third-Quarter Results, Raises Guidance
Bausch Health announced its third-quarter 2026 financial results and raised guidance.
Story updates
08:02:06 PM UTC
SquawkNews
Bausch Health 3Q EPS $1.15 >BHC
08:02:07 PM UTC
SquawkNews
Bausch Health 3Q Adj EPS $1.77 >BHC
08:02:57 PM UTC
SquawkNews
Bausch Health Companies Inc. reported Q3 2026 revenue of $2.94B, up 10% YoY, and adjusted EBITDA of $1.31B. The company raised full-year 2026 guidance and authorized a $50M share repurchase program.Material DetailsContext by AI AnalystThis is a continuation of a multi-quarter growth and deleveragin…
BAUSCH HEALTH EXCLUDING BAUSCH + LOMB THIRD QUARTER 2026 RESULTSLAVAL, QC, Oct. 28, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its third quarter 2026 financial results and other key updates from the quarter."Bau…